PL4346847T3 - Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego - Google Patents
Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennegoInfo
- Publication number
- PL4346847T3 PL4346847T3 PL22732150.2T PL22732150T PL4346847T3 PL 4346847 T3 PL4346847 T3 PL 4346847T3 PL 22732150 T PL22732150 T PL 22732150T PL 4346847 T3 PL4346847 T3 PL 4346847T3
- Authority
- PL
- Poland
- Prior art keywords
- pluri
- prevention
- treatment
- ionic complex
- neurogenic inflammation
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/32—Manganese; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/34—Copper; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Birds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BE20215448A BE1029458B1 (fr) | 2021-06-04 | 2021-06-04 | Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation neurogène |
| PCT/EP2022/065271 WO2022254042A1 (en) | 2021-06-04 | 2022-06-03 | Pluri-ionic complex for the prevention or treatment of neurogenic inflammation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4346847T3 true PL4346847T3 (pl) | 2025-12-01 |
Family
ID=76325316
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL22732150.2T PL4346847T3 (pl) | 2021-06-04 | 2022-06-03 | Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240261323A1 (pl) |
| EP (1) | EP4346847B1 (pl) |
| JP (1) | JP2024520753A (pl) |
| CN (1) | CN117479948A (pl) |
| BE (1) | BE1029458B1 (pl) |
| DK (1) | DK4346847T3 (pl) |
| PL (1) | PL4346847T3 (pl) |
| PT (1) | PT4346847T (pl) |
| WO (1) | WO2022254042A1 (pl) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE1030588B1 (fr) * | 2022-06-03 | 2024-01-08 | Ynios Pharma | Complexe pluri-ionique pour la prévention ou le traitement de l'inflammation |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639625A (en) * | 1967-07-13 | 1972-02-01 | Lewis Sherwin | Compositions containing lithium succinate |
| US5516534A (en) * | 1993-11-26 | 1996-05-14 | Rensselaer Polytechnic Institute | Composition and method for reducing structural defects |
| US6572902B2 (en) * | 2001-04-25 | 2003-06-03 | Advanced H2O, Inc. | Process for producing improved alkaline drinking water and the product produced thereby |
| CA2730009C (en) * | 2007-07-12 | 2017-08-15 | Whipbird Pain Relief Pty Ltd. | Topical medicament |
| AU2008274908B2 (en) * | 2008-07-11 | 2014-08-14 | Whipbird Pain Relief Pty Ltd | Topical medicament |
| CA3150471A1 (en) * | 2008-12-09 | 2010-06-17 | Warburton Technology Limited | Trace element solution for animals |
| KR100943204B1 (ko) * | 2009-07-14 | 2010-02-19 | 주식회사메자이텍 | 혈액순환 개선용 기능성 음용수 및 이의 제조방법 |
| KR101326472B1 (ko) * | 2011-11-28 | 2013-11-08 | 가톨릭대학교 산학협력단 | 광천수를 함유한 비강 세척용 조성물 |
| CN108310287A (zh) * | 2018-04-26 | 2018-07-24 | 深圳安济堂医药科技有限公司 | 治疗癌症的口服液及其制备方法 |
| KR102187895B1 (ko) * | 2019-03-12 | 2020-12-07 | 가톨릭대학교 산학협력단 | 대사성 질환의 예방 또는 치료용 조성물 |
-
2021
- 2021-06-04 BE BE20215448A patent/BE1029458B1/fr active IP Right Grant
-
2022
- 2022-06-03 US US18/566,954 patent/US20240261323A1/en active Pending
- 2022-06-03 JP JP2023575390A patent/JP2024520753A/ja active Pending
- 2022-06-03 CN CN202280040005.XA patent/CN117479948A/zh active Pending
- 2022-06-03 PT PT227321502T patent/PT4346847T/pt unknown
- 2022-06-03 WO PCT/EP2022/065271 patent/WO2022254042A1/en not_active Ceased
- 2022-06-03 EP EP22732150.2A patent/EP4346847B1/en active Active
- 2022-06-03 PL PL22732150.2T patent/PL4346847T3/pl unknown
- 2022-06-03 DK DK22732150.2T patent/DK4346847T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| CN117479948A (zh) | 2024-01-30 |
| BE1029458B1 (fr) | 2023-01-09 |
| WO2022254042A1 (en) | 2022-12-08 |
| EP4346847B1 (en) | 2025-09-17 |
| US20240261323A1 (en) | 2024-08-08 |
| DK4346847T3 (da) | 2025-10-20 |
| EP4346847A1 (en) | 2024-04-10 |
| JP2024520753A (ja) | 2024-05-24 |
| BE1029458A1 (fr) | 2023-01-05 |
| PT4346847T (pt) | 2025-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL3672639T3 (pl) | Produkt kombinowany inhibitora Bcl-2 i ibrutynibu do zastosowania w zapobieganiu i/lub leczeniu nowotworu złośliwego | |
| IL281999A (en) | YAP/TAZ-TEAD interaction inhibitors and their use in cancer therapy | |
| IL288882A (en) | A mixture of plant extracts for use in the prevention and/or treatment of chronic inflammatory bowel diseases | |
| IL273297A (en) | Gluconic acid derivatives for use in the treatment and/or prevention of bacterial infections | |
| IL289371A (en) | Methylthioninium for use in the treatment of synaptopathies | |
| ZA202307970B (en) | Compounds for use in the treatment and prevention of covid- 19 | |
| PL4346847T3 (pl) | Kompleks wielojonowy do stosowania w profilaktyce lub leczeniu zapalenia neurogennego | |
| SG11202107720UA (en) | Cnx/erp57 inhibitor for use in the treatment or prevention of cancer | |
| GB201918413D0 (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
| GB201918414D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
| PL3829553T3 (pl) | Kompozycja do stosowania do zapobiegania i/lub leczenia śluzówki układu moczowo-płciowego | |
| GB201918410D0 (en) | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | |
| PL3758799T3 (pl) | Kompozycja do zapobiegania i traktowania uszkodzeń skóry spowodowanych fotoekspozycją | |
| IL282718A (en) | Compounds for use in the treatment or prevention of pain, inflammation and/or autoimmune diseases | |
| IL282511A (en) | Seaweed extract for use in the treatment or prevention of post-traumatic immunosuppression | |
| GB201918416D0 (en) | Compounds and their use for the treatment of Alpha1-Antitrypsin deficiency | |
| GB2610895C (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL259395B (en) | A cosmetic compound for use in the treatment and prevention of skin with acne | |
| SG11201708214UA (en) | Combination of at least one protease inhibitor and at least one active principle for use in the prevention and/or treatment of skin lesions | |
| HUP1900281A1 (hu) | Monoamin-oxidáz-B gátlók prosztata karcinóma megelõzésében vagy kezelésében történõ alkalmazásra | |
| GB202107297D0 (en) | Composition for use in the treatment and/or prevention of mycotoxic disease | |
| IL261240B (en) | Preparations useful in the prevention and/or treatment of inflammation and pain | |
| PL3813843T3 (pl) | Kompozycja do stosowania w zapobieganiu i/lub leczeniu chorób układu kostno-stawowego | |
| GB2574944B (en) | Methods and compositions for the treatment of pain and/or inflammation | |
| HK40020769A (en) | Composition for use in the prevention and in the treatment of iron deficiency |